Clinical Study of HR20013 for Injection in Patients With Malignant Solid Tumors

Condition:   Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy Interventions:   Drug: HR20013 for injection；dexamethasone;   Drug: fosaprepitant dimeglumine for injection；palonosetron hydrochloride injection；dexamethasone Sponsor:   Fujian Shengdi Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials